TL
Talphera, Inc.
TLPH · NASDAQ
$1.16 -0.85% (-$0.01)
1M -2.52%
Market Cap $60.7M
P/E Ratio -
Div. Yield -
ROE 87.28%
Bulios Fair Price
$0.84
27.6% downside
Current Price
$1.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TLPH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
24 /100
Expensive P/S 60,722.50x
P/B 4.22x
P/E N/A
Growth
0 /100
Declining Book val. growth 7.91%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 1,227,000.00%
Net margin 1,507,600.00%
Quality
0 /100
Poor ROIC 65.20%
Asset turnover 0.00x
ROE 87.28%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.29x
Int. coverage N/A
Stability
37 /100
Moderate Beta 0.69x
Profitable years 0
EPS volatility 98.76%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TLPH
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Vincent J. Angotti
Employees
12
Headquarters
San Mateo
Upcoming events
11 NOV
Earnings
Upcoming earnings report